Financial Data and Key Metrics Changes - The company reported first quarter adjusted diluted EPS of $2.90, consistent with previous expectations, with full-year 2025 adjusted EPS expectations remaining unchanged at greater than $7.25 [5][24][37] - Premium and service revenue for Q1 was $42.5 billion, with an increase in full-year revenue guidance to a midpoint of $165 billion, up from $159 billion [26][38] - The adjusted SG&A expense ratio decreased to 7.9% from 8.7% year-over-year, driven by revenue growth and expense discipline [35] Business Line Data and Key Metrics Changes - Medicaid membership was stable at approximately 12.9 to 13 million members, with a Medicaid HBR of approximately 93%, showing slight improvement from 93.4% in Q4 2024 [27][28] - The Medicare segment performed in line with expectations, with Medicare Advantage membership contributing an additional $1 billion to the 2025 revenue outlook due to better-than-expected retention [16][31] - The commercial segment saw strong growth, with a Q1 HBR of 75.0%, up from 73.3% the previous year, driven by new marketplace members [34] Market Data and Key Metrics Changes - The company noted an increase in bipartisan support for extending health care premium tax credits, with 78% of swing voters supporting the extension [9] - The expiration of enhanced premium tax credits is anticipated to be addressed by Congress, with significant implications for the marketplace [10][23] - The company is preparing for potential impacts from proposed marketplace integrity and affordability rules, which could influence market dynamics starting in 2026 [22][42] Company Strategy and Development Direction - The company is focused on margin recovery and aligning rates with member acuity, with expectations that Medicaid will return to pre-pandemic margin levels [11][13] - Strategic initiatives include expanding Medicaid managed care into rural areas and enhancing the Medicare Advantage value proposition [14][16] - The company is committed to navigating the evolving policy landscape while advocating for sound health care policy [7][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to manage through a dynamic policy landscape, noting that broad support for Medicaid benefit cuts is lacking [7][8] - The company anticipates continued momentum in discussions with state partners regarding rate negotiations and acuity data [75] - Management remains optimistic about long-term growth prospects, emphasizing the attractiveness of end markets and the potential for market share capture [24][25] Other Important Information - The company experienced $130 million in incremental medical expenses due to an active flu season, which offset underlying improvements in medical loss ratio [12][28] - The company is actively engaging with CMS on proposed rules that could impact the marketplace and is preparing for various potential outcomes [22][23] Q&A Session Summary Question: Details on flu-related costs - Management clarified that the $130 million in flu-related costs was tracked using a consistent definition and was isolated to Medicaid, with some flu impact seen in Medicare but not at the same level [49][51] Question: Long-term earnings outlook - Management confirmed that the long-term earnings potential remains optimistic, with opportunities for margin expansion in Medicaid and Medicare segments [54][56] Question: Impact of public exchange subsidies - Management indicated that the estimate of a $1 impact per share from the potential loss of enhanced APTCs remains valid, with ongoing discussions about the implications of work requirements [57][61] Question: Risk adjustment and membership growth - Management noted that risk adjustment numbers are consistent with expectations, and the majority of new membership remains subsidized, aligning with the company's focus on low-income populations [99][96] Question: Specialty drug trends - Management highlighted that specialty drug utilization trends are being closely monitored, particularly in Medicaid, with high-cost drugs impacting overall costs [118][120]

Core Insights - Centene reported $46.62 billion in revenue for Q1 2025, a 15.4% year-over-year increase, with an EPS of $2.90 compared to $2.26 a year ago, exceeding Zacks Consensus Estimates for both revenue and EPS [1] - The company delivered a revenue surprise of +7.24% and an EPS surprise of +22.88% compared to analyst expectations [1] Financial Performance Metrics - Total Medical Health Benefits loss ratio was 87.1%, better than the estimated 87.9% [4] - Membership in High Acuity Medicaid stood at 1.59 million, matching analyst estimates [4] - Medicaid membership reached 12.96 million, slightly above the 12.94 million estimate [4] - SG&A Expense Ratio was 7.9%, lower than the estimated 8.4% [4] - Premium and service revenues totaled $42.49 billion, exceeding the $40.12 billion estimate, reflecting a 16.9% year-over-year increase [4] - Premium revenues were $41.71 billion, surpassing the $39.35 billion estimate, marking a 17.4% year-over-year change [4] - Service revenues were $777 million, slightly above the $768.54 million estimate, but a 3.8% decrease year-over-year [4] - Premium tax revenues were $4.13 billion, exceeding the $3.52 billion estimate, with a 1.5% year-over-year increase [4] - Commercial premium and service revenues reached $10.15 billion, significantly above the $9.04 billion estimate, representing a 30.9% year-over-year increase [4] - Medicare premium and service revenues were $8.76 billion, exceeding the $8.54 billion estimate, with a 47.6% year-over-year increase [4] - Medicaid premium and service revenues totaled $22.30 billion, above the $21.45 billion estimate, reflecting a 3.9% year-over-year increase [4] - Other premium and service revenues were $1.28 billion, exceeding the $1.22 billion estimate, with a 7.6% year-over-year increase [4] Stock Performance - Centene's shares returned +2.2% over the past month, contrasting with the Zacks S&P 500 composite's -4.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Centene (CNC) came out with quarterly earnings of $2.90 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.26 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 22.88%. A quarter ago, it was expected that this healthcare company would post earnings of $0.49 per share when it actually produced earnings of $0.80, delivering a surprise of 63.27%.Over the last four quarters, the compan ...

-- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024. 17% year-over-year premium and service revenue growth. Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024. Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Ce ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ ____________________________________________ Commission file number: 001-31826 ____________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ____________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ...

Core Insights - A collaboration between Health Net, Dignity Health, and Vivant Health has significantly improved care coordination for Medi-Cal members in Sacramento County, reducing unnecessary hospital days and increasing follow-up appointments [1][2][3] Group 1: Partnership Impact - The initiative has avoided over 400 unnecessary inpatient days in hospitals, showcasing the effectiveness of the collaborative approach [6] - There has been a 20-percentage point increase in the percentage of patients who had a primary care provider or specialist follow-up appointment after discharge, rising from 76% to 96% [6] - The partnership emphasizes tailored care for patients, enhancing the overall patient experience and setting new healthcare standards [3][4] Group 2: Care Model and Social Determinants - The collaboration integrates new care models aligned with California's CalAIM program, addressing individual social needs such as housing and care navigation [3][4] - A multidisciplinary team, including physicians, nurses, case managers, and social workers, focuses on social determinants of health, significantly improving patient outcomes [4] Group 3: Organizational Background - Health Net, a Centene Corporation company, serves over three million members in California and offers a range of health plans and services [5] - Dignity Health operates a multi-state nonprofit network with over 10,000 physicians and 60,000 employees, dedicated to providing affordable patient-centered care [7] - Vivant Health has been a leader in healthcare innovation for over 30 years, serving over 300,000 patients in California and promoting health equity [8]

Core Viewpoint - Centene Corporation (CNC) is expected to report its first-quarter 2025 results on April 25, with earnings estimated at $2.36 per share and revenues at $43.47 billion, indicating year-over-year growth in both metrics [1] Financial Estimates - The Zacks Consensus Estimate for Centene's revenues for the current year is $172.83 billion, reflecting a 6% year-over-year increase, while the EPS estimate is $7.13, indicating a slight decline of 0.6% year-over-year [3] - The earnings estimate for Q1 has remained stable over the past week, with a year-over-year increase of 4.4% projected [1][2] - The consensus estimate for quarterly revenues suggests a year-over-year growth of 7.6% [1] Earnings Performance - Centene has beaten the consensus estimate for earnings in three of the last four quarters, with an average surprise of 21.8% [3] - The company has an Earnings ESP of +8.17% and a Zacks Rank of 3 (Hold), indicating a favorable outlook for an earnings beat [4] Revenue Drivers - Revenue growth in Q1 is expected to be supported by higher premiums, with the Zacks Consensus Estimate for premiums at $39.4 billion, suggesting a 10.8% year-over-year increase [5] - The total memberships are projected to increase by 3% year-over-year, primarily driven by growth in the commercial marketplace unit [5] Medicare Revenue - The Zacks Consensus Estimate for revenues from Medicare is pegged at $8.5 billion, indicating a significant year-over-year increase of 43.9% [6] Cost Considerations - The total Health Benefit Ratio (HBR) for Q1 is estimated at 87.85%, up from 87.10% a year ago, which may partially offset revenue growth [7] - Total operating expenses are expected to grow by 7.1% year-over-year due to higher medical costs [8]

Core Insights - Health Net announced a $3.5 million grant to MLK Community Medical Group to enhance healthcare services in Los Angeles by hiring essential clinical staff [1][4] - The grant aims to address the rising demand for healthcare services and the shortage of clinical professionals, which has made it challenging for patients to receive timely care [3][4] - Health Net's commitment to workforce development includes a recent investment of over $9 million to grow California's physician pipeline [4] Company Overview - Health Net, a subsidiary of Centene Corporation, has been operating in California for over 45 years, providing health plans for various demographics, including those eligible for Medi-Cal and Medicare [6] - The company serves more than three million members and has a network of over 117,000 providers across the state [6] - Health Net is dedicated to transforming community health and employs over 5,700 people in California [6]

Analysts on Wall Street project that Centene (CNC) will announce quarterly earnings of $2.36 per share in its forthcoming report, representing an increase of 4.4% year over year. Revenues are projected to reach $43.47 billion, increasing 7.6% from the same quarter last year.The current level reflects a downward revision of 1.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections ove ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Centene (CNC) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 25. On the o ...